June 24, 2026 - Patel Jeegar Pravinkumar - 4: Statement of changes in beneficial ownership of securities | Evommune, Inc. (EVMN)
SEC Form 4
| FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
# STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 | | | OMB Number: | 3235-0287 |
| --- | --- | --- | --- | --- |
| Estimated average burden | hours per response: | 0.5 | | |
| OMB APPROVAL | |
|---|---|
| --- | --- |
| X |
| 1. Name and Address of Reporting Person* | |||
| --- | --- | --- | --- |
| Patel Jeegar Pravinkumar | |||
| (Last) | (First) | (Middle) | |
| --- | --- | --- | --- |
| C/O EVOMMUNE, INC. | |||
| 1891 PAGE MILL ROAD | |||
| --- | --- | --- | --- |
| PALO ALTO | CA | 94304 | |
| --- | --- | --- | --- |
| (City) | (State) | (Zip) |
(Check all applicable)
| Director | 10% Owner | ||
| X | Officer (give title below) | Other (specify below) | |
| Chief Scientific Officer | |||
| 3. Date of Earliest Transaction (Month/Day/Year) 06/22/2026 |
|||
| 4. If Amendment, Date of Original Filed (Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line) | ||
| --- | --- | ||
| X | Form filed by One Reporting Person | ||
| Form filed by More than One Reporting Person |
| 1. Title of Security (Instr. 3) |
2. Transaction Date (Month/Day/Year) |
2A. Deemed Execution Date, if any (Month/Day/Year) |
3. Transaction Code (Instr. 8) |
4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) |
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) |
7. Nature of Indirect Beneficial Ownership (Instr. 4) |
|---|---|---|---|---|---|---|---|
| Code | V | Amount | (A) or (D) | Price | |||
| :-: | :-: | :-: | :-: | :-: | |||
| Common Stock | 06/22/2026 | M(1) | 1,488 | A | $3.84 | ||
| Common Stock | 06/22/2026 | S(1) | 1,488 | D | $22.5 |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
| 1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) |
3A. Deemed Execution Date, if any (Month/Day/Year) |
4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| :-: | :-: | :-: | :-: | :-: | :-: | :-: | :-: | ||||
| Employee Stock Option (Right to Buy) | $3.84 | 06/22/2026 | M(1) | 1,488 | (2) | 05/11/2033 | Common Stock | 1,488 |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
| Explanation of Responses: |
| 1. The transactions were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2026. |
| 2. One fourth (1/4) of the shares subject to the option award shall vest on the first anniversary of the grant date and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date. |
| Remarks: |
| --- |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.